Pfizer PFE Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.76B+18.8% | $1.2B+8.1% | $1.39B+21.0% | $1.69B+50.8% | $1.48B+89.9% | ||
| $11.37B-28.4% | $12.45B-35.9% | $13.64B+54.0% | $11.61B+92.0% | $15.89B+41.7% | ||
| $12.59B+6.2% | $11.87B+3.6% | $14.26B-1.3% | $12.08B+6.0% | $11.85B+7.8% | ||
| $2.46B-11.9% | $2.37B-11.0% | $2.14B-22.5% | $2.36B-19.1% | $2.79B-16.9% | ||
| $42.82B-6.6% | $42.9B-14.8% | $46.92B+8.6% | $43.7B+15.5% | $45.86B+8.1% | ||
| $19.4B+5.8% | $19.32B+5.0% | $18.88B+1.8% | $18.78B-1.0% | $18.35B-2.4% | ||
| $71.41B+4.3% | $71.26B+4.0% | $69.1B+0.8% | $69B+0.8% | $68.44B-1.2% | ||
| $207.62B-0.2% | $208.16B-2.5% | $208.73B-4.9% | $206.1B-4.7% | $208.03B-5.9% | ||
| $4.51B-14.0% | $5.24B-7.0% | $5.02B-5.5% | $5.17B+1.2% | $5.24B-6.3% | ||
| $3.86B+3.0% | $3B-20.0% | $4.25B+13.4% | $4.25B+13.4% | $3.75B+275% | ||
| $34.35B-5.8% | $36.98B-14.0% | $36.6B-15.3% | $37.73B-13.9% | $36.45B-10.0% | ||
| $60.57B+5.1% | $61.64B+7.4% | $57.41B-1.0% | $57.5B0.0% | $57.64B-6.0% | ||
| $3.41B-97.1% | $3.25B-97.4% | $115.64B-8.9% | $117.08B-8.7% | $117.39B-8.7% | ||
| $117.24B-2.0% | $114.61B-1.8% | $121.15B+0.1% | $117.61B+0.9% | $119.59B-1.4% | ||
| $90.1B-0.3% | $86.48B-2.0% | $92.8B+0.6% | $88.7B+1.1% | $90.34B-2.1% | ||
| $207.62B-0.2% | $208.16B-2.5% | $208.73B-4.9% | $206.1B-4.7% | $208.03B-5.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pfizer's total assets?
- Pfizer (PFE) holds $207.62B in total assets, down 0.2% year over year.
- How much debt does Pfizer have?
- Pfizer carries $64.4B in total debt against $90.1B of shareholders' equity, a debt-to-equity ratio of 0.71.
- How much cash does Pfizer have?
- Pfizer holds $1.8B in cash and equivalents.
- Can Pfizer cover its short-term obligations?
- Its current ratio is 1.25 — current assets exceed current liabilities.
- Where does Pfizer's balance sheet data come from?
- Every line is extracted from Pfizer's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
